These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 31365378)
61. [Interstitial lung diseases : Classification, differential diagnosis and treatment approaches in a heterogeneous group of chronic lung disorders]. Lederer C; Buschulte K; Hellmich B; Heußel CP; Kriegsmann M; Polke M; Kreuter M Inn Med (Heidelb); 2023 Mar; 64(3):247-259. PubMed ID: 36786822 [TBL] [Abstract][Full Text] [Related]
62. Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF. Tóth NM; Müller V; Nagy T; Polivka L; Horváth P; Bohács A; Eszes N Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298130 [TBL] [Abstract][Full Text] [Related]
64. Serum C-reactive protein is associated with earlier mortality across different interstitial lung diseases. Stock CJW; Bray WG; Kouranos V; Jacob J; Kokosi M; George PM; Chua F; Wells AU; Sestini P; Renzoni EA Respirology; 2024 Mar; 29(3):228-234. PubMed ID: 37779266 [TBL] [Abstract][Full Text] [Related]
65. Factors influencing long-term outcomes in fibrotic interstitial lung disease (F-ILD) diagnosed through multidisciplinary discussion (MDD): a prospective cohort study. Liao YW; Liu MC; Wu YC; Hsu CY; Huang WN; Chen YH; Fu PK Eur J Med Res; 2024 Jan; 29(1):91. PubMed ID: 38291459 [TBL] [Abstract][Full Text] [Related]
66. Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases. Mononen M; Saari E; Hasala H; Kettunen HP; Suoranta S; Nurmi H; Kärkkäinen M; Selander T; Randell J; Laurikka J; Uibu T; Koskela H; Kaarteenaho R; Purokivi M BMC Pulm Med; 2022 Aug; 22(1):313. PubMed ID: 35965320 [TBL] [Abstract][Full Text] [Related]
67. Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease. Suda T Clin Med Insights Circ Respir Pulm Med; 2015; 9(Suppl 1):155-62. PubMed ID: 27279757 [TBL] [Abstract][Full Text] [Related]
68. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers. Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A Respiration; 2020; 99(10):838-845. PubMed ID: 33264777 [TBL] [Abstract][Full Text] [Related]
69. Role of Multidisciplinary Team Meetings in the Diagnosis and Management of Diffuse Parenchymal Lung Diseases in a Tertiary Care Hospital. Khan MA; Sherbini N; Alyami S; Al-Harbi A; Alrajhi S; Abdullah R; AlGhamdi D; Rajendram R; Bamefleh H; Al-Jahdali H Avicenna J Med; 2023 Oct; 13(4):230-236. PubMed ID: 38144909 [No Abstract] [Full Text] [Related]
70. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060 [TBL] [Abstract][Full Text] [Related]
71. The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease-A Systematic Review. Puiu R; Motoc NS; Lucaciu S; Ruta MV; Rajnoveanu RM; Todea DA; Man MA Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540667 [TBL] [Abstract][Full Text] [Related]
72. Immunomodulatory treatment of interstitial lung disease. van den Bosch L; Luppi F; Ferrara G; Mura M Ther Adv Respir Dis; 2022; 16():17534666221117002. PubMed ID: 35938712 [TBL] [Abstract][Full Text] [Related]
80. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis. Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]